Increasing evidence indicates that overexpression of anti-apoptotic Bcl-2 family members, such as Bcl-2, Bcl-xL, and Mcl-1, is a major factor in breast cancer initiation (Adams and Cory, 2018), and is often associated with poor prognosis. This evidence concerns the gene BCL2 and breast carcinoma.